Understanding Stakeholders' Perspectives to Increase COVID‐19 Vaccine and Booster Uptake Among Black Individuals With Rheumatic Conditions

N Ezeh, G Sirek, SN Ulysse, JN Williams… - Arthritis Care & …, 2023 - Wiley Online Library
Objective Disparities in COVID‐19 vaccine and booster uptake persist. This study aimed to
obtain perspectives from community and physician stakeholders on COVID‐19 vaccine and …

Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys

P Sen, N Houshmand, S Moghadam Kia, M Joshi… - …, 2023 - academic.oup.com
Objective COVID-19 vaccines have a favorable safety profile in patients with autoimmune
rheumatic diseases (AIRDs) such as idiopathic inflammatory myopathies (IIMs); however …

[HTML][HTML] Perspectives and experiences of COVID-19 vaccination in people with autoimmune and inflammatory rheumatic disease

D Peng, A Kelly, B Brady, K Faasse… - Patient Education and …, 2024 - Elsevier
Objective People with autoimmune and inflammatory rheumatic disease (AIIRD) are at an
increased risk of morbidity from COVID-19. While COVID-19 vaccination is effective at …

Efficacy and safety of inactivated SARS‐CoV‐2 vaccination in COVID‐19‐associated pneumonia among patients with rheumatic and musculoskeletal diseases: A real …

S Liu, Z Jin, X Feng, Z Da, Y Tang, H Hu… - International Journal …, 2024 - Wiley Online Library
Objectives To identify the effectiveness and safety of inactivated SARS‐CoV‐2 vaccines in
rheumatic and musculoskeletal diseases (RMDs) patients. Methods RMD patients with …

Comment on: COVID-19 vaccine hesitancy in inflammatory arthritis patients: serial surveys from a large longitudinal national Australian cohort

R Mungmunpuntipantip, V Wiwanitkit - Rheumatology, 2023 - academic.oup.com
DEAR EDITOR, We would like to share ideas on 'COVID-19 vaccine hesitancy in
inflammatory arthritis patients: serial surveys from a large longitudinal national Australian …